LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 206 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $143,000 | -13.3% | 1,177 | -24.3% | 0.06% | +3.5% |
| Q1 2017 | $165,000 | +5.8% | 1,555 | +1.0% | 0.06% | +11.8% |
| Q4 2016 | $156,000 | -3.1% | 1,540 | -2.2% | 0.05% | +2.0% |
| Q3 2016 | $161,000 | -10.6% | 1,575 | +4.3% | 0.05% | -12.3% |
| Q2 2016 | $180,000 | +1536.4% | 1,510 | +1410.0% | 0.06% | +1800.0% |
| Q1 2016 | $11,000 | +37.5% | 100 | +42.9% | 0.00% | +50.0% |
| Q4 2015 | $8,000 | +14.3% | 70 | +7.7% | 0.00% | +100.0% |
| Q2 2015 | $7,000 | -94.8% | 65 | -97.7% | 0.00% | -97.2% |
| Q3 2014 | $135,000 | – | 2,875 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |